Elsevier Launches Open Access Journal: Internet Interventions

AMSTERDAM, March 19, 2014 /PRNewswire/ --

New  OA  journal  Internet  Interventions  publishes  research  on  the  application  of  information  technology  
in  mental  and  behavioral  healthcare

Elsevier, a world-leading provider of scientific, technical and medical (STM) information products and services, is pleased to announce the launch of the Open Access, online-only journal Internet Interventions. The journal is published in affiliation with the International Society for Research on Internet Interventions (ISRII) and the European Society for Research on Internet Interventions (ESRII).

The internet is increasingly used for delivering interventions aimed at improving mental and physical health. Internet interventions - often self-guided or partly self-guided - have in the past proven effective in treating a number of psychiatric conditions, including among others: depression, panic disorder, social anxiety disorder, insomnia, as well as more general medical conditions, such as headache, back pain, tinnitus and smoking cessation.

Today's increased focus on internet interventions can be explained by its global applicability, and cost efficiency. Technological advances allow for novel intervention components, such as user-friendly visual screening instruments, video-based exposure therapy, interactive role-playing, automated reasoning models, all lowering the help-seeking threshold.

"With the approval of government and medical insurers, use of Internet interventions for treatment have already been integrated into the regular healthcare systems in the US and UK, and in Sweden, the Netherlands and Australia, to name a few examples. This new journal will provide a home for high quality research papers on the application of information technology in mental and behavioral healthcare," said Prof. Gerhard Andersson, Editor-in-Chief  Internet  Interventions.

"Mental health problems have great impact on all societies across the globe; they are significant contributors to the burden of disease and the loss of quality of life, and have huge economic and social costs. Despite the increasingly large number of papers published on the topic of e-mental health over the past decade, until today there was no dedicated peer-reviewed scientific journal to collect this research," said Lisa Colson, Associate Publisher at Elsevier. "Internet  Interventions fills this gap and we are proud to work with the leading experts in this emerging research area; Professors Gerhard Andersson of Linköping University, Per Carlbring of Stockholm University and Heleen Riper of the Vrije University Amsterdam, who together head up the Editorial Leadership of the journal."

Internet  Interventions follows the article based publishing model which allows for immediate publication of the final version of a paper without waiting for other articles to be ready to compile a full issue.

First articles published in Internet  Interventions are now available on ScienceDirect.

For more information about the journal or to submit an article, go to: http://www.invent-journal.com.

About  the  ESRII

A non-profit organization committed to advancing the scientific approach to studying eHealth interventions. ESRII is a group of researchers, clinicians and policy experts whose mission is to foster excellence in evidence-based eHealth interventions targeting behavioral and mental health. Web site: http://www.ESRII.eu

About  ISRII

A non-profit interdisciplinary organization committed to advancing the scientific approach to studying eHealth interventions and information and communication technologies targeting behavioral and mental health. ISRII is a group of researchers, clinicians, developers, coordinators, economists, policy experts and industry associates whose mission is to foster excellence in evidence-based eHealth interventions targeting behavioral and mental health. http://www.isrii.org

About  Open  Access  Publishing  at  Elsevier

Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as 92 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess

About  Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media  contact
Natalie Hill-krasniqi
Elsevier
+44(0)20-7424-4404
n.hill-krasniqi@elsevier.com

SOURCE Elsevier



More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.